Stephen is the Royal Pharmaceutical Society Correspondent for The Journal. He reports on the activities of the Society and edits the Your RPS section. In 2011, he was awarded Medical Journalist of the Year (Professional Media) by the Medical Journalists' Association (MJA).
- 020 7572 2392
A UK pharmaceutical company’s “unacceptable” advisory board meeting, highlighted in a series of Daily Telegraph articles in July 2015, breached the industry’s code of practice, the regulator has ruled.
The government faces a strong backlash from community pharmacy bodies over plans to cut the community pharmacy contractual framework in England by 6.1% in 2016.
Five out of six women at high risk of breast cancer decline preventive medication, and those who opt for treatment often fail to take the drugs for long enough for them to have the full effect, according to the findings of a meta-analysis.
Contraceptive implant linked to repeat abortionSubscription
Pharmacy faces up to the urgent care challengeSubscription
Who decides the true value of a medicine?Subscription